DFSCoin (CURRENCY:DFS) traded flat against the dollar during the 1-day period ending at 18:00 PM E.T. on May 25th. One DFSCoin coin can currently be purchased for approximately $0.0722 or 0.00000810 BTC on popular exchanges. DFSCoin has a market cap of $1.28 million and $0.00 worth of DFSCoin was traded on exchanges in the last 24 hours. Over the last seven days, DFSCoin has traded down 3.6% against the dollar.
Here is how other cryptocurrencies have performed over the last 24 hours:
Get DFSCoin alerts:
TokenPay (TPAY) traded down 4.8% against the dollar and now trades at $3.68 or 0.00049717 BTC. SaluS (SLS) traded 1.3% lower against the dollar and now trades at $38.15 or 0.00515254 BTC. ECC (ECC) traded down 5% against the dollar and now trades at $0.0009 or 0.00000012 BTC. VeriCoin (VRC) traded down 1.3% against the dollar and now trades at $0.47 or 0.00006394 BTC. Linda (LINDA) traded down 3.6% against the dollar and now trades at $0.0012 or 0.00000016 BTC. LoMoCoin (LMC) traded 3.2% lower against the dollar and now trades at $0.0429 or 0.00000580 BTC. Profile Utility Token (PUT) traded down 14.9% against the dollar and now trades at $0.21 or 0.00002771 BTC. OKCash (OK) traded 5.3% lower against the dollar and now trades at $0.12 or 0.00001589 BTC. Gambit (GAM) traded 3.7% lower against the dollar and now trades at $6.48 or 0.00087501 BTC. ToaCoin (TOA) traded up 4.9% against the dollar and now trades at $0.0028 or 0.00000037 BTC.
Hot Stocks To Buy Right Now: CGI Group, Inc.(GIB)
The mission of CGI is to help its clients with professional services of outstanding quality, competence and objectivity, delivering the best solutions to fully satisfy client objectives in information technology (“IT”), business processes and management. In all we do, we foster a culture of partnership, intrapreneurship and integrity, building a global IT and business process services company.
CGI is unique compared to most companies. We not only have a vision, but also a dream: “To create an environment in which we enjoy working together and, as owners, contribute to building a company we can be proud of.” This dream has motivated us since our founding in 1976 and drives our vision: “To be a global, world-class IT and business process services leader helping our clients succeed. Advisors’ Opinion:
- [By Logan Wallace]
Get a free copy of the Zacks research report on CGI (GIB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Shares of CGI (TSE:GIB.A) (NYSE:GIB) have been assigned a consensus recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is C$88.70.
Hot Stocks To Buy Right Now: Tallgrass Energy Partners, LP(TEP)
Tallgrass Energy Partners, LP (NYSE:TEP) is a growth-oriented publicly traded Delaware limited partnership formed in February 2013 by Tallgrass Development to own, operate, acquire and develop midstream energy assets in North America. We provide natural gas transportation and storage services for customers in the Rocky Mountain and Midwest regions of the United States through our Tallgrass Interstate Gas Transmission System, which we refer to as the TIGT System, and provide processing services for customers in Wyoming through our Casper and Douglas natural gas processing and West Frenchie Draw natural gas treating facilities, which we refer to as the Midstream Facilities. Advisors’ Opinion:
- [By Logan Wallace]
Natixis bought a new position in Tallgrass Energy Partners LP (NYSE:TEP) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 68,685 shares of the pipeline company’s stock, valued at approximately $2,975,000. Natixis owned 0.09% of Tallgrass Energy Partners as of its most recent filing with the Securities & Exchange Commission.
- [By Joseph Griffin]
JPMorgan Chase & Co. trimmed its position in shares of Tallgrass Energy Partners LP (NYSE:TEP) by 21.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 686,632 shares of the pipeline company’s stock after selling 190,040 shares during the period. JPMorgan Chase & Co. owned approximately 0.94% of Tallgrass Energy Partners worth $26,016,000 at the end of the most recent quarter.
Hot Stocks To Buy Right Now: Can-Fite Biopharma Ltd(CANF)
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. It offers CF101, which has completed Phase II/III clinical trials for the treatment of psoriasis; completed Phase II clinical trials for the treatment of rheumatoid arthritis; completed Phase I clinical study for the treatment of osteoarthritis; and completed Phase I study for the treatment of uveitis, as well as is in Phase II clinical trials for the treatment of glaucoma or related syndromes of ocular hypertension. The company also develops CF102 that conducts a Phase II study for treating HCC and HCV; and CF602, which is in pre-clinical trial for the treatment of inflammatory diseases. Can-Fite BioPharma Ltd. is headquartered in Petah-Tikva, Israel.
- [By Max Byerly]
CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a large drop in short interest in the month of June. As of June 29th, there was short interest totalling 302,241 shares, a drop of 14.1% from the June 15th total of 351,936 shares. Based on an average daily volume of 208,682 shares, the short-interest ratio is presently 1.4 days.
- [By Shane Hupp]
Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
- [By Shane Hupp]
Media headlines about Can-Fite Biopharma (NASDAQ:CANF) have trended positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 44.6620747072303 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Hot Stocks To Buy Right Now: Liberty Tax, Inc.(TAX)
Liberty Tax, Inc., incorporated on October 23, 2010, is the holding company for JTH Tax, Inc. The Company is a provider of tax preparation services. The Company provides retail federal and state income tax preparation services and related tax settlement products in the United States and Canada. The Company’s tax preparation services and related tax settlement products are offered primarily through franchised locations. All of the Company’s offices are operated under the Liberty Tax Service and SiempreTax+ brands. The Company also provides an online digital Do-It-Yourself (DIY) tax program in the United States.
The Company offers two types of tax settlement financial products: refund transfer products, which include providing a means by which a customer receives his or her refund, and refund-based loans. The Company’s LibTax software allows tax customers to have their federal and state income tax returns filed electronically.
The Company competes with H&R Block, Jackson Hewitt, Intuit, Inc. and Blucora, Inc.
- [By Stephan Byrd]
Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.
Hot Stocks To Buy Right Now: Sigma Designs, Inc.(SIGM)
We are a global integrated semiconductor solutions provider offering intelligent media platforms for use in the home entertainment and home control markets. Our goal is to ensure that our solutions serve as the foundation for some of the world’s leading consumer products, including televisions, set-top boxes, media connectivity and home control devices. Our business generates revenue primarily by delivery of relevant, cost-effective semiconductors that are targeted toward end-product manufacturers, Original Equipment Manufacturers, or OEMs, and Original Design Manufacturers, or ODMs. We also derive a portion of our revenue from other products and services, including technology licenses, software development kits, engineering support services for hardware and software, engineering development for customization of chipsets and other accessories. Advisors’ Opinion:
- [By Ethan Ryder]
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
Get Arcturus Therapeutics alerts:
Don’t Miss This Stock: Arcturus Therapeutics Ltd. (ARCT),Issuer Direct Corporation (ISDR) (bitcoinpriceupdate.review) Blustering Stocks: Camtek Ltd. (NASDAQ:CAMT), Attis Industries, Inc. (NASDAQ:ATIS), Arcturus Therapeutics Ltd … (journalfinance.net) Digging Into the Earnings & Quant Data For These Shares: Arcturus Therapeutics Ltd. (NasdaqGM:ARCT), Lumber … (zeelandpress.com) Average True Range to Consider Before Investment Blink Charging Co. (NASDAQ:BLNK), Inuvo, Inc. (NYSE:INUV … (stocksnewspoint.com) Extremely Informative stocks: Sigma Designs, Inc. (NASDAQ:SIGM), Attis Industries, Inc. (NASDAQ:ATIS), Arcturus … (thestreetpoint.com)
Shares of Arcturus Therapeutics stock traded up $0.05 during trading on Friday, hitting $8.10. 32,713 shares of the stock traded hands, compared to its average volume of 14,625. The firm has a market capitalization of $86.38 million, a PE ratio of -2.29 and a beta of 1.18. Arcturus Therapeutics has a 52 week low of $4.78 and a 52 week high of $15.19.
- [By Steve Symington]
Data source: Silicon Laboratories.
What happened with Silicon Labs this quarter?
Revenue was above the high end of guidance provided in late January, which called for a range of $196 million to $202 million. On an adjusted (non-GAAP) basis, which excludes items like equity compensation and acquisition costs, net income was $38.3 million, or $0.87 per share — also above guidance for adjusted earnings per share of between $0.73 and $0.79. IoT revenue grew 17% year over year to $103 million. Infrastructure revenue jumped 37% year over year to $49 million. Broadcast revenue declined 3% to $36 million. Access revenue fell 6% to $17 million. Subsequent to the end of the quarter, on April 18, 2018, Silicon Labs closed its $240 million acquisition of Sigma Designs’ (NASDAQ:SIGM) Z-Wave business. Silicon Labs had initially agreed to acquire all of Sigma Designs this past December for $282 million, but amended the deal last quarter to include only its Z-Wave business after certain closing conditions weren’t met. In any case, the purchase significantly expands Silicon Labs’ position in mesh networking for smart homes.
What management had to say
Silicon Labs CEO Tyson Tuttle said: